Upgrade to SI Premium - Free Trial

Gilead Sciences shares gain after topping expectations despite lower remdesivir sales

February 3, 2023 9:46 AM
Gilead Sciences (NASDAQ: GILD) shares rallied in early Friday trading in reaction to the company's latest earnings report, which saw ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Earnings Guidance Hot List

Next Articles